Related Experiment Videos

Policy challenges for the pediatric rheumatology workforce: Part III. the international situation

Michael Henrickson1

  • 1Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA. michael.henrickson@cchmc.org.

Insights

Pediatric musculoskeletal disease burden is largely unknown globally. Innovative strategies like telemedicine and physician extenders are crucial for improving access to care in underserved regions.

Area of Science:

  • Global pediatric health
  • Musculoskeletal medicine
  • Rheumatic diseases

Background:

  • Pediatric survival is a global health priority, with poverty-related diseases causing significant mortality.
  • Musculoskeletal diseases contribute minimally to pediatric mortality but their global morbidity is largely unknown.
  • Developing nations face a growing burden of chronic conditions, including musculoskeletal and rheumatic diseases.

Purpose of the Study:

  • To highlight the unknown global burden of pediatric musculoskeletal disease.
  • To explore innovative strategies for improving access to care for these conditions.
  • To address the projected shortage of pediatric rheumatology workforce.

Main Methods:

  • Review of existing literature on pediatric global health and musculoskeletal disease epidemiology.
  • Analysis of workforce challenges in pediatric rheumatology.
  • Exploration of innovative healthcare delivery models, including telemedicine and physician extenders.

Main Results:

  • Global data on pediatric musculoskeletal disease morbidity is lacking.
  • A significant shortage of pediatric rheumatology specialists is projected.
  • Physician extenders and telemedicine show promise in bridging access gaps.

Conclusions:

  • Creative strategies are essential to address the growing need for pediatric musculoskeletal care globally.
  • Investing in physician extender training and telemedicine can improve access in underserved areas.
  • Further research is needed to accurately assess the global burden of pediatric rheumatic diseases.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...